According to a new market report published by Lucintel, the future of the bovine blood plasma derivative market looks promising with opportunities in the pharmaceutical, medical diagnostic, biotechnology, research & development, nutrition supplement, food, and cosmetic industries. The global bovine blood plasma derivative market is expected to grow with a CAGR of 6% from 2020 to 2025. The major drivers for this market are rising demand for albumin as an excipient in the pharmaceutical industry and increasing usage of animal by-products in cell culture technology.
To download report brochure, please go to https://www.lucintel.com/bovine-blood-plasma-derivative-market.aspx and click "download brochure" tab from the menu
Bovine blood plasma derivatives are products containing proteins that are procured from the blood plasma of bovine animals with the help of physico-chemical or other fractionation processes. In this market, immunoglobulin, fibrinogen, bovine serum albumin, fetal bovine serum, thrombin, transferrin, new born calf serum, and BGG (Bovine Gamma Globulin) are the major derivative types. Lucintel forecasts that thrombin will remain the largest derivative type segment over the forecast period due to increasing research and development activities, such as in-vitro study and protein structure analysis.
Asia Pacific is expected to witness the highest growth over the forecast period due to increasing government initiatives and approvals to export products, such as cattle protein and serum, from the region.
GE Healthcare, Sigma-Aldrich, Lampire Biological Laboratories, Proliant, Rocky Mountain Biologicals, Bovogen Biologicals, Thermo Fisher Scientific, Kraeber, Auckland BioSciences, and Lake Immunogenics are among the major suppliers in the global bovine blood plasma derivative market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global bovine blood plasma derivative market by derivative type, application, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Bovine Blood Plasma Derivative Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global bovine blood plasma derivative market by derivative type, application, and region as follows:
By Derivative Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Immunoglobulin
Fibrinogen
Bovine Serum Albumin
Fetal Bovine Serum
Thrombin
Transferrin
New Born Calf Serum
BGG (Bovine Gamma-Globulin)
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Pharmaceutical Industry
Diagnostic Industry
Cell Culture or Biotechnology
Research and Development
Food Industry
Cosmetic Industry
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
France
This more than 150 page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.